II

Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023

Retrieved on: 
Tuesday, March 14, 2023
Oncology, Health, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, ULK, Cancer, Research, Integrated stress response, AACR, Abstract, Encorafenib, Cetuximab, BRAF, Gastrointestinal stromal tumor, Autophagy, III, Exon, Growth, GIST, Colorectal cancer, RAF, KIT, Preclinical SPECT, GCN2, Investigational New Drug, II, IND, Pharmaceutical industry, Vaccine, Medical imaging

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced the presentation of eight posters at the upcoming AACR Annual Meeting 2023, taking place in Orlando, Florida on April 14-19, 2023.

Key Points: 
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced the presentation of eight posters at the upcoming AACR Annual Meeting 2023, taking place in Orlando, Florida on April 14-19, 2023.
  • The Company will also host a virtual investor event on Tuesday, April 18 at 6:30 PM ET.
  • A webcast of the event will be available in the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations .
  • The archived webcast will be available on the Company’s website within 24 hours after the event and will be available for 30 days following the event.

LG COLLABORATES WITH NCAA BASKETBALL PLAYERS TO RAISE MENTAL HEALTH AWARENESS AMONG STUDENT-ATHLETES

Retrieved on: 
Wednesday, March 15, 2023
Well, Jarace Walker, Stanford University, CBS, Education, True Love (video game), Organization, Division II, DI, CBS Sports, Louisiana State University, NCAA Division II, 3D, NCAA Division I men's basketball tournament, Sport, II, Division, Anxiety, XR, Mental disorder, National Alliance, Partnership, Save, Indiana University, Warner Bros. Discovery Sports, III, NCAA, LG Electronics, Name, Student, Marketing, Electronics, Katie McGregor, University, Depression, Hope, Ben 10, NCAA Final Four (Philippines), Character, Rivalry, NAMI, OLED, Charity (practice), Athlete, Research, National Alliance on Mental Illness, Ice, Mental health, University of Houston, Nursing, Metaverse, LG

ENGLEWOOD CLIFFS, N.J., March 15, 2023 /PRNewswire/ -- LG Electronics USA announced today the launch of its "Game 4 Good" campaign that brings together some of the biggest names in college basketball during the 2023 NCAA March Madness tournaments to highlight the importance of mental health and wellness among student-athletes. This new initiative builds on LG's three-year partnership with the NCAA as an official corporate partner.

Key Points: 
  • As part of the initiative, LG will donate $10,000 to each athlete partner's mental health charity of choice.
  • Haley Jones has chosen Katie's Save , an initiative that supports students and sports teams of all age levels by spreading mental health awareness.
  • Jarace Walker selected the National Alliance of Mental Illness (NAMI) , the nation's largest grassroots mental health organization focused on mental health advocacy, education, support, and public awareness for mental illness.
  • New episodes will be taped during the NCAA tournament featuring student athletes, mental health experts, faculty administrators and more.

Parsonex Capital Partners Breaks Ground on Third Qualified Opportunity Zone Project

Retrieved on: 
Tuesday, March 14, 2023
Realtor.com, Arroyo Grande Community Hospital, City, II, Natural Resources, Community, Miller, Single-family, Recreation, Skiing, Community hospital, The Wall Street Journal, III, Grand Junction, Colorado, Projection, Partnership, Housing, Rare-earth element, Tourism, Metropolitan statistical area

ENGLEWOOD, Colo., March 14, 2023 /PRNewswire/ -- Earlier last week, Parsonex Capital Partners ("Parsonex") announced it has broken ground on its third Qualified Opportunity Zone ("QOZ"), a development project located in Grand Junction, Colorado.

Key Points: 
  • ENGLEWOOD, Colo., March 14, 2023 /PRNewswire/ -- Earlier last week, Parsonex Capital Partners ("Parsonex") announced it has broken ground on its third Qualified Opportunity Zone ("QOZ"), a development project located in Grand Junction, Colorado.
  • The project, known as Canyonview Villas, is being co-developed by Senergy Builders and will be located across from the Community Hospital in Grand Junction, Colorado.
  • These units will be part of a Master Plan Community, consisting of townhouses, retail stores, senior living facilities and medical offices.
  • According to Miller, "Parsonex is eager to continue our cherished partnership with Senergy Builders and the City of Grand Junction.

N. Joyce Payne Center for Social Justice Promoting Civic Engagement & Voter Registration at Historically Black Colleges & Universities

Retrieved on: 
Saturday, March 11, 2023
Civic, Livingstone College, Woman, Pitt Community College, Southwest Voter Registration Education Project, Get out the vote, Education, Social justice, North Carolina Central University, Fayetteville State University, Shaw University, Social, Social media, Voter registration, Engagement, Mobilization, VFC, University, Integration, Historically black colleges and universities, Research, Elizabeth City State University, Student, Information, II, Winston-Salem State University, GOTV, COVID-19, Partnership, Nursing

Washington, March 11, 2023 (GLOBE NEWSWIRE) -- The N. Joyce Payne Center for Social Justice (PCSJ) and the National Historically Black Colleges & Universities Alumni Associations Foundation (NHBCUAAF) continue their partnership to promote civic engagement and voter registration at the nation’s HBCUs.

Key Points: 
  • Washington, March 11, 2023 (GLOBE NEWSWIRE) -- The N. Joyce Payne Center for Social Justice (PCSJ) and the National Historically Black Colleges & Universities Alumni Associations Foundation (NHBCUAAF) continue their partnership to promote civic engagement and voter registration at the nation’s HBCUs.
  • In 2020, the American Association of Colleges & Universities reported that young adults had been the least engaged members of the US electorate for more than four decades.
  • Tufts University’s Center for Information and Research on Civic Learning and Engagement report found that the American electorate is growing younger and more diverse.
  • “We are extremely excited to continue working with the NHBCUAAF in bringing progressive voices together to promote and affirm the power of civic engagement,” said Dr. Christopher C. Brown, II, Executive Director, Payne Center for Social Justice.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Honda Motor Co., Ltd. of Class Action Lawsuit and Upcoming Deadline – HMC

Retrieved on: 
Friday, March 10, 2023
Odyssey, Acura, Disclosure, Motorcycle, Court, American Honda Motor Company, HMC, ADS, Honda, News, LLP, District court, System, Person, Ext, Complaint, Car, TLX, Aircraft pilot, Risk, Marketing, Central District, II, Safety, SEC Rule 10b-5, NYSE, Action Replay, Passport, Pomerantz, Automotive industry

NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Honda Motor Co., Ltd. (NYSE: HMC), and certain officers.

Key Points: 
  • NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Honda Motor Co., Ltd. (NYSE: HMC), and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • The Company’s U.S.-based operations are conducted through its North American subsidiary, American Honda Motor Company, Inc. (“American Honda”).
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, March 9, 2023
Diamond, Black Diamond, Glioblastoma, IND, BRAF, Clinical trial, MAP, EORTC, Mutation, Treatment, Development, R, Neoplasm, Cancer, RAF, Administration, Research, Patient, FDA, Investigational New Drug, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lung cancer, NEA, RAS, II, Food, Toxic encephalopathy, Myenteric plexus, EGFR, FGFR, Brain, Investment, M26 Modular Accessory Shotgun System, Drug discovery, European Organisation for Research and Treatment of Cancer, III, NSCLC, Poster, GBM, Pharmaceutical industry, Cryptocurrency, Launch pad, G&A

We’ve designed a robust pipeline of products with brain penetration properties to address these key challenges,” said David Epstein, Ph.D., President and Chief Executive Officer of Black Diamond.

Key Points: 
  • We’ve designed a robust pipeline of products with brain penetration properties to address these key challenges,” said David Epstein, Ph.D., President and Chief Executive Officer of Black Diamond.
  • In the first quarter of 2023, Black Diamond received allowance of its IND application from the FDA.
  • Cash Position: Black Diamond ended 2022 with approximately $122.8 million in cash, cash equivalents, and investments compared to $209.8 million as of December 31, 2021.
  • Net Loss: Net loss for the fourth quarter of 2022 was $21.1 million, as compared to $25.9 million for the same period in 2021.

LiquidityBook Expands Proprietary FIX Network LBX Connect in Europe, Continues 2023 “EMEA in Focus” Initiative

Retrieved on: 
Wednesday, March 8, 2023
Street, Investment, FX, FIX, Connect, Tag Team (group), Markets in Financial Instruments Directive 2014, ALGO, Harman Connected Services, II, LBX, Documentation, Clearwater Analytics, Support, API, Intelligence, Video game

NEW YORK AND LONDON, March 08, 2023 (GLOBE NEWSWIRE) -- LiquidityBook, a leading provider of cloud-native buy- and sell-side trading solutions, today announced its plans to make continued investments to significantly expand LBX Connect, the firm’s proprietary managed FIX network, across Europe.

Key Points: 
  • NEW YORK AND LONDON, March 08, 2023 (GLOBE NEWSWIRE) -- LiquidityBook, a leading provider of cloud-native buy- and sell-side trading solutions, today announced its plans to make continued investments to significantly expand LBX Connect, the firm’s proprietary managed FIX network, across Europe.
  • LBX Connect is built around a flexible FIX gateway with multi-asset capabilities that include integrated, real-time risk controls, as well as post-trade capabilities supporting clearing and settlement.
  • LBX Connect enables LiquidityBook clients to leverage robust normalization logic to support different versions of FIX, including support for a raft of broker algo suites.
  • LiquidityBook has provided FIX connectivity services since our founding, and we have seen LBX Connect truly flourish under Sumit’s technical direction.”
    Today, more than 25% of LBX Connect destinations route to EMEA.

C & C Heating & Air Conditioning celebrates Women's History Month by advocating for more women in the skilled trades

Retrieved on: 
Friday, March 10, 2023
Women's History Month, Family, Learning, Baby boomers, Woman, Economics, C & C, C&C Yachts, II, American women in World War I, HVAC, Nursing

DETROIT, March 10, 2023 /PRNewswire/ -- As the general manager of C & C Heating & Air Conditioning, a leading Detroit-area heating and cooling company, Dayna Hottle says that more women should consider a career in the skilled trades, especially as a labor shortage in the industry means there are job openings and the pay is lucrative.

Key Points: 
  • "Learning a skilled trade is ideal for women who want to follow a technical career path but don't want to rack up thousands in student loan debt by attending a college.
  • HVAC techs, plumbers and electricians are jobs that can't be outsourced and they are all good-paying jobs with desirable benefits.
  • March is Women's History Month , and Hottle points to times in America's history when most trade and manufacturing jobs were staffed by women.
  • For more information about C & C Heating & Air Conditioning, call (586) 439-3319.

TAGRISSO® (osimertinib) demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer

Retrieved on: 
Thursday, March 9, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Cough, MD, Stage, DFS, QT interval, Wireless ambulatory ECG, Diagnosis, Heart, AstraZeneca, Mutation, Electrolyte, Lung cancer, Fever, LVEF, LAURA, EGFR, Recurrence, Medicine, Lung, Cardiomyopathy, Yale Cancer Center, Patient, NSCLC, Rated R, ILD, Survival, Periodic breathing, IB, Doctor of Philosophy, QT, Safety, II, Medical imaging, Pharmaceutical industry, Vaccine

In May 2020 , AstraZeneca announced TAGRISSO demonstrated a statistically significant and clinically meaningful improvement in disease-free survival (DFS) in this setting.

Key Points: 
  • In May 2020 , AstraZeneca announced TAGRISSO demonstrated a statistically significant and clinically meaningful improvement in disease-free survival (DFS) in this setting.
  • Per the ADAURA trial protocol, patients on placebo that recurred with metastatic disease had the opportunity to receive open-label TAGRISSO.
  • AstraZeneca has a comprehensive portfolio of approved and potential new medicines in development for patients with lung cancer.
  • Interstitial lung disease (ILD)/pneumonitis occurred in 3.7% of the 1479 TAGRISSO-treated patients; 0.3% of cases were fatal.

IMFINZI significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable non-small cell lung cancer

Retrieved on: 
Thursday, March 9, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, MD, OS, DFS, Incidence, AstraZeneca, MD Anderson Cancer Center, Pneumonitis, Lung cancer, MPR, Warning, PCR, EFS, Radiation, Recurrence, Administration, Durvalumab, Patient, NSCLC, Rated R, Prednisone, Survival, University, Infection, IB, Creatinine, Doctor of Philosophy, Overalls, Safety, II, Pharmaceutical industry, Medical imaging, Vaccine, AEGEAN

The trial will continue as planned to assess key secondary endpoints including disease-free survival (DFS) and overall survival (OS).

Key Points: 
  • The trial will continue as planned to assess key secondary endpoints including disease-free survival (DFS) and overall survival (OS).
  • We have shown that adding IMFINZI both before and after surgery significantly increased the time patients live without recurrence or progression events.
  • AstraZeneca has a comprehensive portfolio of approved and potential new medicines in development for patients with lung cancer.
  • Immune-mediated colitis occurred in 2% (37/1889) of patients receiving IMFINZI, including Grade 4 (